119 related articles for article (PubMed ID: 2546630)
1. Montreal platelet syndrome: a defect in calcium-activated neutral proteinase (calpain).
Okita JR; Frojmovic MM; Kristopeit S; Wong T; Kunicki TJ
Blood; 1989 Aug; 74(2):715-21. PubMed ID: 2546630
[TBL] [Abstract][Full Text] [Related]
2. Spontaneous platelet aggregation in a hereditary giant platelet syndrome (MPS).
Milton JG; Frojmovic MM; Tang SS; White JG
Am J Pathol; 1984 Feb; 114(2):336-45. PubMed ID: 6696046
[TBL] [Abstract][Full Text] [Related]
3. Activation of calpain I and hydrolysis of calpain substrates (actin-binding protein, glycoprotein Ib, and talin) are not a function of thrombin-induced platelet aggregation.
Wencel-Drake JD; Okita JR; Annis DS; Kunicki TJ
Arterioscler Thromb; 1991; 11(4):882-91. PubMed ID: 1905952
[TBL] [Abstract][Full Text] [Related]
4. Shape-changing agents produce abnormally large platelets in a hereditary "giant platelets syndrome (MPS)".
Milton JG; Frojmovic MM
J Lab Clin Med; 1979 Jan; 93(1):154-61. PubMed ID: 759524
[TBL] [Abstract][Full Text] [Related]
5. Thrombin-induced platelet aggregation involves an indirect proteolytic cleavage of aggregin by calpain.
Puri RN; Zhou FX; Bradford H; Hu CJ; Colman RF; Colman RW
Arch Biochem Biophys; 1989 Jun; 271(2):346-58. PubMed ID: 2543293
[TBL] [Abstract][Full Text] [Related]
6. Platelet size and shape in hereditary giant platelet syndromes on blood smear and in suspension: evidence for two types of abnormalities.
Milton JG; Hutton RA; Tuddenham EG; Frojmovic MM
J Lab Clin Med; 1985 Sep; 106(3):326-35. PubMed ID: 4031633
[TBL] [Abstract][Full Text] [Related]
7. Calpain proteolysis of von Willebrand factor enhances its binding to platelet membrane glycoprotein IIb/IIIa: an explanation for platelet aggregation in thrombotic thrombocytopenic purpura.
Moore JC; Murphy WG; Kelton JG
Br J Haematol; 1990 Apr; 74(4):457-64. PubMed ID: 2346725
[TBL] [Abstract][Full Text] [Related]
8. Thrombasthenia with an abnormal platelet membrane glycoprotein IIb of different molecular weight.
Jung SM; Yoshida N; Aoki N; Tanoue K; Yamazaki H; Moroi M
Blood; 1988 Apr; 71(4):915-22. PubMed ID: 3355897
[TBL] [Abstract][Full Text] [Related]
9. Calpain I remains intact and intracellular during platelet activation. Immunochemical measurements with monoclonal and polyclonal antibodies.
Samis JA; Zboril G; Elce JS
Biochem J; 1987 Sep; 246(2):481-8. PubMed ID: 2825639
[TBL] [Abstract][Full Text] [Related]
10. Physical, chemical and functional changes following platelet activation in normal and "giant" platelets.
Frojmovic MM; Milton JG
Blood Cells; 1983; 9(2):359-82. PubMed ID: 6362754
[TBL] [Abstract][Full Text] [Related]
11. Dicer cleavage by calpain determines platelet microRNA levels and function in diabetes.
Elgheznawy A; Shi L; Hu J; Wittig I; Laban H; Pircher J; Mann A; Provost P; Randriamboavonjy V; Fleming I
Circ Res; 2015 Jul; 117(2):157-65. PubMed ID: 25944670
[TBL] [Abstract][Full Text] [Related]
12. Specific protein and glycoprotein deficiencies in platelets isolated from two patients with the gray platelet syndrome.
Nurden AT; Kunicki TJ; Dupuis D; Soria C; Caen JP
Blood; 1982 Apr; 59(4):709-18. PubMed ID: 6460535
[TBL] [Abstract][Full Text] [Related]
13. A platelet disorder due to a structural abnormality of membrane glycoprotein Ib.
Meyer M; Schellenberg I; Hofmann B; Vogel G
Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(4):515-8. PubMed ID: 2465964
[TBL] [Abstract][Full Text] [Related]
14. Platelet adhesion enhances the glycoprotein VI-dependent procoagulant response: Involvement of p38 MAP kinase and calpain.
Siljander P; Farndale RW; Feijge MA; Comfurius P; Kos S; Bevers EM; Heemskerk JW
Arterioscler Thromb Vasc Biol; 2001 Apr; 21(4):618-27. PubMed ID: 11304481
[TBL] [Abstract][Full Text] [Related]
15. Evidence that agonist-induced activation of calpain causes the shedding of procoagulant-containing microvesicles from the membrane of aggregating platelets.
Fox JE; Austin CD; Reynolds CC; Steffen PK
J Biol Chem; 1991 Jul; 266(20):13289-95. PubMed ID: 2071604
[TBL] [Abstract][Full Text] [Related]
16. Membrane expression of platelet calpain.
Schmaier AH; Bradford HN; Lundberg D; Farber A; Colman RW
Blood; 1990 Mar; 75(6):1273-81. PubMed ID: 2310827
[TBL] [Abstract][Full Text] [Related]
17. [Immunochemical study of protein anomalies in platelets of patients with Glanzmann's thrombasthenia and Bernard-Soulier syndrome].
Nurden AT; Hagen I; Kunicki T; Caen JP
C R Seances Acad Sci D; 1979 Jul; 289(2):209-11. PubMed ID: 117927
[TBL] [Abstract][Full Text] [Related]
18. The action of calcium-dependent protease on platelet surface glycoproteins.
McGowan EB; Yeo KT; Detwiler TC
Arch Biochem Biophys; 1983 Nov; 227(1):287-301. PubMed ID: 6314909
[TBL] [Abstract][Full Text] [Related]
19. Calpain regulation of cytoskeletal signaling complexes in von Willebrand factor-stimulated platelets. Distinct roles for glycoprotein Ib-V-IX and glycoprotein IIb-IIIa (integrin alphaIIbbeta3) in von Willebrand factor-induced signal transduction.
Yuan Y; Dopheide SM; Ivanidis C; Salem HH; Jackson SP
J Biol Chem; 1997 Aug; 272(35):21847-54. PubMed ID: 9268316
[TBL] [Abstract][Full Text] [Related]
20. Effect of platelet calpain on normal T-lymphocyte CD43: hypothesis of events in the Wiskott-Aldrich syndrome.
Remold-O'Donnell E; Van Brocklyn J; Kenney DM
Blood; 1992 Apr; 79(7):1754-62. PubMed ID: 1558970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
